Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US3755581036
Ticker GILD
Company GILEAD SCIENCES
Currency $
Price
Aware Investor Index (AII) 65.8522
Recommendation STRONG BUY
P/E 12.61
ROE 31.49 %
Capitalization 85,477,800,000 $
Dividend Yield 3.49 %
P/S 3.86
AII Position 50
P/E Position 118
ROE Position 88
Capitalization Position 105
Dividend Yield Position 203
Sales 22,127,000,000 $
10-Year Average Earnings 6,780,002,300 $
Shares Outstanding 1,308,000,000
Equity 21,534,000,000 $
Dividend per Share 2.28 $
Industry Biotechnology
Country United States
GILEAD SCIENCES Investor Relations Web Site http://investors.gilead.com







Sales:

YEAR MONTH AMOUNT
2018 12 22,127,000,000.00 $
2017 12 26,107,000,000.00 $
2016 12 30,390,000,000.00 $
2015 12 32,639,000,000.00 $
2014 12 24,890,000,000.00 $
2013 12 11,201,680,000.00 $
2012 12 9,702,000,000.00 $
2011 12 8,385,000,000.00 $
2010 12 7,949,000,000.00 $
2009 12 7,011,000,000.00 $

Earnings:

YEAR MONTH AMOUNT
2018 12 5,455,000,000.00 $
2017 12 4,628,000,000.00 $
2016 12 13,501,000,000.00 $
2015 12 18,108,000,000.00 $
2014 12 12,101,000,000.00 $
2013 12 3,074,808,000.00 $
2012 12 2,591,566,000.00 $
2011 12 2,803,637,000.00 $
2010 12 2,901,257,000.00 $
2009 12 2,635,755,000.00 $

Equity:

YEAR MONTH AMOUNT
2018 12 21,534,000,000.00 $
2017 12 20,501,000,000.00 $
2016 12 19,363,000,000.00 $
2015 12 19,113,000,000.00 $
2014 12 15,819,000,000.00 $
2013 12 11,744,501,000.00 $
2012 12 9,550,869,000.00 $
2011 12 6,867,349,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2018 12 1,308,000,000
2017 12 1,319,000,000
2016 12 1,358,000,000
2015 12 1,521,000,000
2014 12 1,647,000,000
2013 12 1,694,747,000
2012 12 1,582,549,000
2011 12 1,580,236,000

 












Bloomberg News for GILEAD SCIENCES:



Google News for GILEAD SCIENCES:

The Dwinnex - 42 minutes ago
Gilead Sciences, Inc. [GILD] – A Stock with value that transcends ...
Gilead Sciences, Inc.[GILD] stock saw a move by 1.66% on Thursday, touching 2.23 million. Based on the recent volume, Gilead Sciences, Inc.
Curious Coins (press release)
Gilead Sciences (GILD) Stock Sinks As Market Gains: What You ...
In the latest trading session, Gilead Sciences (GILD) closed at $65.23, marking a -0.18% move from the previous day. This change lagged the ...
Ws News Publisher
Gilead Sciences (GILD): Outshine Stock with Glowing Scores
Gilead Sciences (GILD) Stock Under Technical Focus. Reading RSI Indicator: Gilead Sciences (GILD) got attention from day Traders as RSI ...
US Post News
Gilead Sciences (GILD) Expected to Beat Earnings Estimates: Can ...
Wall Street expects a year-over-year decline in earnings on higher revenues when Gilead Sciences (GILD) reports results for the quarter ended ...
Yahoo Finance - 4 days ago
Will Strong HIV Sales Drive Gilead's (GILD) Q3 Earnings?
Biotech major Gilead Sciences Inc. GILD is slated to report third-quarter 2019 results on Oct 24, after market close. Gilead has a pretty decent ...
Viral News Place - 11 hours ago
Gilead Just Named a New CFO. Is More Deal Making on the Way?
A c-suite reshuffle at the Gilead Sciences (ticker: GILD) means more drug development deals are on the way for the biotech firm, according to a ...
Yahoo Finance - 5 days ago
New Gilead CFO: Let's Make a Deal
With Andrew Dickinson assuming the additional role of chief financial officer at Gilead Sciences (NASDAQ:GILD), the company appears poised ...
Yahoo Finance - 4 days ago
Better Buy: Gilead Sciences vs. Johnson & Johnson
Gilead Sciences (NASDAQ:GILD) and Johnson & Johnson (NYSE:JNJ) have competed against each other for years in the HIV market.
Barron's - 15 Oct 2019
Better Buy: Biogen vs. Gilead Sciences
Biogen (NASDAQ:BIIB) and Gilead Sciences (NASDAQ:GILD) are both biotech royalty. In the not-so-distant past, these two top biotech stocks ...
The Dwinnex
Better Buy: Gilead Sciences vs. Pfizer
And among the big drug stocks, few offer dividends as attractive as those of Gilead Sciences (NASDAQ:GILD) and Pfizer (NYSE:PFE).


Back